商湯(00020.HK)續跌逾4%再創新低 科指則升1.7%
商湯(00020.HK)雖然澄清公司執董兼控股股東湯曉鷗並無出售其實益持有的任何公司股份,也沒有出售公司股份計劃,對集團長期價值及前景充滿信心。然而,基石投資者禁售期屆滿該股表現持續弱勢,至今天已五連跌,並再創上市新低,最低見2.25元,現報2.29元,續跌4.2%,爲表現最差科指成份股,成交達1億股,已接近昨天全日成交量1.18億股。
反映中概股表現的納斯達克金龍中國指數昨晚升1.3%;本港科指兩連彈,現報4,625即市高位,續升1.7%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.